Recent investigations conducted by Borkar et al. (33) and Grzybowski et al. (34) have substantiated the safety of same-day bilateral intravitreal anti-VEGF treatment, reporting no instances of endophthalmitis in a collective total of 1,612 bilateral injections. This evidence concerns the gene VEGFA and endophthalmitis.